产品中心
当前位置：首页>产品中心Anti-ASB8/Cy3
货号： bs-9132R-Cy3 基本售价： 2980.0 元 规格： 100ul
产品信息
- 产品编号
- bs-9132R-Cy3
- 英文名称
- Anti-ASB8/Cy3
- 中文名称
- Cy3标记的含锚蛋白重复序列-细胞因子信号抑制物盒蛋白家族8抗体
- 别 名
- Ankyrin repeat and SOCS box containing 8; Ankyrin repeat and SOCS box protein 8; ASB 8; ASB-8; ASB8; ASB8_HUMAN; FLJ21255; MGC5540; PP14212.
- 规格价格
- 100ul/2980元购买 大包装/询价
- 说 明 书
- 100ul
- 研究领域
- 细胞生物 免疫学 细胞周期蛋白
- 抗体来源
- Rabbit
- 克隆类型
- Polyclonal
- 交叉反应
- Human, Mouse, Rat,
- 产品应用
- IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
- 分 子 量
- 32kDa
- 性 状
- Lyophilized or Liquid
- 浓 度
- 1mg/ml
- 免 疫 原
- KLH conjugated synthetic peptide derived from human ASB8
- 亚 型
- IgG
- 纯化方法
- affinity purified by Protein A
- 储 存 液
- 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
- 保存条件
- Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
- 产品介绍
- background:
May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Function:
May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity).
Subcellular Location:
Cytoplasm
Tissue Specificity:
Highest level of expression in skeletal muscle. Also expressed in heart, brain, placenta, liver, kidney and pancreas.
Similarity:
Contains 4 ANK repeats.
Contains 1 SOCS box domain.
Database links:
UniProtKB/Swiss-Prot: Q9H765.1
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.